CN104857018B - Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics - Google Patents

Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics Download PDF

Info

Publication number
CN104857018B
CN104857018B CN201510169863.6A CN201510169863A CN104857018B CN 104857018 B CN104857018 B CN 104857018B CN 201510169863 A CN201510169863 A CN 201510169863A CN 104857018 B CN104857018 B CN 104857018B
Authority
CN
China
Prior art keywords
raspberry
polysaccharide
taxol
purposes
raspberry polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510169863.6A
Other languages
Chinese (zh)
Other versions
CN104857018A (en
Inventor
索有瑞
杨永晶
叶英
韩丽娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest Institute of Plateau Biology of CAS
Original Assignee
Northwest Institute of Plateau Biology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest Institute of Plateau Biology of CAS filed Critical Northwest Institute of Plateau Biology of CAS
Priority to CN201510169863.6A priority Critical patent/CN104857018B/en
Publication of CN104857018A publication Critical patent/CN104857018A/en
Application granted granted Critical
Publication of CN104857018B publication Critical patent/CN104857018B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides raspberry polysaccharide and purposes of the chemotherapeutics in antitumor combination medicine is prepared.Pharmacodynamic experiment result shows, raspberry polysaccharide, which has, improves immunity of organisms, strengthens chemicals antitumous effect, the advantages that reducing its toxic side effect.

Description

Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics
Technical field
The invention belongs to medical sci-tech field, and in particular to the drug combination of raspberry polysaccharide and chemotherapeutics.
Technical background
Raspberry (Rubus idaeus L.) also known as Rubus corchorifolius, raspberry, raspberry etc., belong to rose family rubus.Raspberry master Northern Hemisphere temperate zone and frigid zone are distributed in, its fruit sweet slightly sour to starch small aggregate fruit more.Raspberry contains polysaccharide, organic acid, Huang The various active composition such as ketone, anthocyanidin, polyphenol, vitamin, mineral element, volatile oil, tannin, have high nutritive value and Medical care effect, it is described as " gold fruit ".
Polyoses content is high in raspberry, and polysaccharide yield may be up to 12%, is a kind of preferably Polyose extraction raw material.Research hair Existing, polysaccharide has regulation immunity of organisms, antitumor, anti-oxidant, antibacterial, radiation proof, antifatigue, reducing blood sugar and blood fat etc. a variety of Physiologically active.Raspberry product in the market is mainly food, fruit juice, jam, fruit wine such as using raspberry as main component. The polysaccharide of great activity value in raspberry is extracted, and the example for being applied to health products is considerably less, and using raspberry polysaccharide as work The lozenge researches of property composition.
Malignant tumour is still the major disease of serious threat human life.Nearest statistics shows that China is new every year It was found that the people of cancer patient about 20,000,000, wherein 1,500,000 people die from cancer.The death toll of cancer accounts for the 1/5 of total death toll.
Currently, the most frequently used method for the treatment of cancer is still chemotherapy.But due to the nonspecific cell toxicant of chemicals Property, the serious side effect such as bone marrow suppression, mucositis, dermatitis, diarrhoea can be produced.In addition, tumor patient is after multiple chemotherapy Easily develop immunity to drugs, so that the effect of chemotherapy is had a greatly reduced quality.The maximum drawback for the embolic chemotherapy applied at present is it The immune system of body is inhibited, cancer cell is easily escaped the immunosurveillance of body so as to become more menace.Cause This, it is extremely urgent to find safer and more effective treatment method.In recent years, the immunotherapy of tumour has turned into the new heat of oncotherapy Point.So-called immunization therapy, broadly refer to by transferring body self immune system come one kind side for the treatment of to anti-malignant tumor Method.At present, existing such medicine enters clinical investigation phase.
Polysaccharide is that one kind is widely present in animals and plants, has the large biological molecule of a variety of physiologically actives.In recent years, due to Naturally, nontoxic characteristic and it is good the effect of, polysaccharide has become the new midicinal resources of a kind of great exploitation potential.Immunological regulation It is the most important physiologically active of polysaccharide.Research shows that lentinan, GL-B, sea grass polysaccharide, flat beautiful snail polysaccharide etc. all have Good immunological enhancement.But polysaccharide is used with chemotherapy drugs in combination also fewer to treat the example of tumour.
The content of the invention
It is an object of the invention to provide the new application of raspberry polysaccharide.
Specifically, the invention provides raspberry polysaccharide and use of the chemotherapeutics in antitumor combination medicine is prepared On the way.
Wherein, the chemotherapeutics is selected from taxol, cis-platinum or/and docetaxel.
Wherein, the tumour is selected from melanoma, lung cancer, liver cancer, stomach cancer, breast cancer, kidney, carcinoma of endometrium or colon Cancer.
Wherein, the chemotherapeutics uses injection type.Wherein, the injection type can be selected from hypodermic injection, muscle Usual way in the various tumor therapeutic procedures such as injection or intravenous injection.
Wherein, the raspberry polysaccharide uses peroral dosage form.Wherein, the peroral dosage form be selected from tablet, capsule, pill, Granule, powder, extract or oral liquid.
Further, the dosage of raspberry polysaccharide and chemotherapeutics ratio is 20~40: 1w/w, and certainly, this ratio is The confirmation carried out with zoopery, in human body in actual use it is possible that the deviation of dosage use ratio.
Wherein, in the raspberry polysaccharide, purity of polysaccharide is more than 50%;Further, purity of polysaccharide is more than 80%;More Further, purity of polysaccharide is more than 85%;Preferably, purity of polysaccharide is 85~95%w/w, such as moderate purity of the present invention be 90~ 92%.Above-mentioned purity is determined using Phenol-sulphate acid method.
Wherein, the raspberry polysaccharide is prepared using water extraction and alcohol precipitation method.
Further, the water extraction and alcohol precipitation method concrete operations are as follows:Take dry raspberry, after petroleum ether or ether defatting, use 75~95%v/v of concentration ethanol extracts, filtering, filter residue extracting in water, after water intaking extract concentration, adds ethanol to alcohol content to reach 75%~85%, cooling, stand, it is raspberry polysaccharide to take solid content.
Wherein, remove seed or non-remove seed before raspberry extraction.
Wherein, the raspberry is the fruit of rose family rubus plant.
Further, the raspberry is selected from raspberry or black raspberry.
Present invention research is found, raspberry polysaccharide and chemotherapy drugs in combination are used, and for the treatment of malignant tumour, is had and is carried High immunity of organisms, strengthen chemicals antitumous effect, the advantages that reducing its toxic side effect.
Brief description of the drawings:
1 chemotherapeutics of accompanying drawing~raspberry polysaccharide combines the influence to tumor-bearing mice liver organization form;
2 chemotherapeutics of accompanying drawing~raspberry polysaccharide combines the influence to tumor-bearing mice renal tissue form;
3 chemotherapeutics of accompanying drawing~raspberry polysaccharide combines the influence to C57BL/6 mouse spleen indexes;
Influence of the raspberry polysaccharide of accompanying drawing 4 to tumor-bearing mice splenic lymphocytes in-vitro multiplication;
5 chemotherapeutics of accompanying drawing~raspberry polysaccharide combines the influence to Related Immune Enzyme Activity in tumor-bearing mice splenocyte;
6 chemotherapeutics of accompanying drawing~raspberry polysaccharide combine to CD4, CD8, IL in tumor-bearing mice serum~2, INF~γ and The influence of TNF~alpha content.
Embodiment
The raspberry polysaccharide used in the specific embodiment of the invention is prepared into using conventional Polyose extraction, way of purification Arrive, concrete operations are as follows in the present invention:
It is prepared by raspberry polysaccharide:Dry raspberry is taken, after crushing remove seed, adds 5 times of petroleum ethers (60~90 DEG C of boiling range) degreasing, eliminates stone 75%~95%v/v ethanol is added after oily ether in 60 DEG C of backflows, the filter residue after filtering is added into 10 times of pure water ultrasonic extraction (power 60W, temperature:80 DEG C, processing time:100min), centrifuging and taking supernatant, filter residue are extracted twice, merging filtrate, subtracted again by old terms Pressure is concentrated into the 1/4 of original volume, and adding 95% ethanol makes solution alcohol content reach 75%v/v, and 24h is stood in 4 degrees Celsius, and filtering is received Collect filter residue, filter residue dries to obtain raspberry polysaccharide.
After measured, the raspberry polysaccharide yield that prepared by the present invention is 10.4%~11.6%, detects to obtain through Phenol-sulphate acid method Purity of polysaccharide is 90.8%~91.2%.
The present invention is in terms of tumor-inhibiting action, attenuation synergistic and immunological regulation three to the main component tree of raspberry polysaccharide buccal tablet Certain kind of berries polysaccharide has carried out the pharmacodynamic study of adjuvant for chemotherapy of tumour, and raspberry polysaccharide dosage is in terms of polysaccharide in each embodiment.
Embodiment 1
Docetaxel~raspberry polysaccharide combines the inhibitory action to the growth of melanin tumour b16 F10 mouse xenograft tumors
Take the logarithm the melanoma cells B16F10 in growth period, is aseptically prepared into 5 × 107/ ml cell suspensions, It is subcutaneous that C57BL/6 right side of mice armpits are inoculated in 0.1ml.Vernier caliper measurement mice-transplanted tumor diameter is used after 5 days, treats tumour Grow to 60~90mm3Animal is grouped at random afterwards.Use the method in measurement knurl footpath, the antitumor effect of dynamic observation subject medicine Fruit.The pendulous frequency of diameter of tumor is every 2 days 1 time, and measurement every time also needs to weigh mouse weight simultaneously.Packet and administering mode are as follows: Docetaxel group 10mg/kg, is administered once for every three days using being subcutaneously injected.High administering drug combinations in docetaxel~raspberry polysaccharide Group, docetaxel 10mg/kg, are administered once, raspberry polysaccharide uses gavage, and dosage is respectively for every three days using being subcutaneously injected 200mg/kg, 400mg/kg, it is administered once daily.Negative control group injects normal saline, 1 time a day.Gross tumor volume calculates Formula:TV=0.52 × a × b2, wherein a, b represent length and width respectively.Relative tumour volume is calculated according to the result of measurement.It is anti- The evaluation index of tumor promotion is Relative tumor proliferation rate T/C (%), calculation formula:T/C (%)=TRTV/CRTV× 100%, TRTV:Treatment group RTV;CRTV:Negative control group RTV.
The inhibitory action that 1. docetaxels of table~raspberry polysaccharide drug combination grows to C57BL/6 mouse xenograft tumors
As a result:1 is shown in Table, docetaxel 10mg/kg groups are to the tumour inhibiting rate of melanin tumour b16 F10 mice-transplanted tumors 66.49% administering drug combinations group is respectively 70.90% and 74.30% to the tumour inhibiting rate of melanin tumour b16 F10 mice-transplanted tumors.Connection Close and the inhibition of melanoma is used alone higher than docetaxel when using.And docetaxel toxicity is larger, animal body Decline substantially again, animal has death in experimentation.After both are used in combination, experimental animal body weight is tested without being decreased obviously During do not occur animal dead.
Therefore, melanin tumour b16 F10 mice-transplanted tumors growth inhibition test result shows, compared with negative control group, respectively Growth inhibitory action (* P < 0.05, * * P < with conspicuousness of the individual administration group group to melanin tumour b16 F10 mice-transplanted tumors 0.01).Growth of the high administering drug combinations group to melanin tumour b16 F10 mice-transplanted tumors has aobvious in docetaxel~raspberry polysaccharide The inhibitory action of work property, and the inhibition of the high administering drug combinations group of docetaxel~raspberry polysaccharide is higher than docetaxel independent medication Group (ΔP < 0.05).Illustrate that raspberry polysaccharide can strengthen the anti-tumor capacity of docetaxel.In addition, compared with docetaxel, raspberry Polysaccharide has no significant effect to the body weight of experimental animal, has no obvious toxicity.
Embodiment 2
Cis-platinum~raspberry polysaccharide is combined to human lung cancer H460 nude mouse xenograft knurl growth inhibition tests
Take the logarithm the tumour cell in growth period, be aseptically prepared into 5 × 107/ ml cell suspensions, are connect with 0.1ml Kind armpit on the right side of nude mice is subcutaneous.With vernier caliper measurement transplanted tumor in nude mice diameter, treat tumour growth to 100~200mm3After move Thing is grouped at random.Using the method in measurement knurl footpath, dynamic observes antitumous effect.The pendulous frequency of diameter of tumor is every 2 days 1 Secondary, measurement every time also needs to weigh mouse weight simultaneously.Administering mode is as follows:Negative control group injects normal saline, 1 time a day; Cis-platinum group 10mg/kg, weekly administration 1 time;High administering drug combinations group in cis-platinum~raspberry polysaccharide, cis-platinum is using hypodermic injection, 10mg/ Kg, weekly administration 1 time, raspberry polysaccharide use gavage, and dosage is respectively 200mg/kg, 400mg/kg, is administered once daily. Gross tumor volume calculation formula:
TV=0.52 × a × b2
Wherein a, b represent length and width respectively.Relative tumour volume is calculated according to the result of measurement.The evaluation of antitumor activity Index is Relative tumor proliferation rate T/C (%), and calculation formula is as follows:
T/C (%)=TRTV/CRTV× 100%
TRTV:Treatment group RTV;CRTV:Negative control group RTV
The inhibitory action that 2. cis-platinums of table~raspberry polysaccharide drug combination grows to human lung cancer H460 nude mouse xenograft tumors
As a result:2 are shown in Table, cis-platinum 10mg/kg groups are 61.49% to the tumour inhibiting rate of human lung cancer H460 transplanted tumor in nude mice;Cis-platinum It is respectively 65.90%, 72.30% to the tumour inhibiting rate of human lung cancer H460 transplanted tumor in nude mice that~raspberry polysaccharide, which combines middle and high dosage group,. Wherein, the inhibition of the high administering drug combinations group of cis-platinum~raspberry polysaccharide is higher than cis-platinum independent medication group.In addition, toxicity of cisplatin compared with Greatly, the weight of animals declines obvious, and animal has death in experimentation.After both are used in combination, experimental animal body weight is without under obvious Drop, and do not occur animal dead in experimentation.
Therefore, human lung cancer H460 transplanted tumor in nude mice growth inhibition test results are shown, compared with negative control group, cis-platinum Growth of 10mg/kg groups, cis-platinum~the raspberry polysaccharide senior middle school administering drug combinations group to human lung cancer H460 transplantable tumors has pole conspicuousness Inhibitory action (* P < 0.05, * * P < 0.01).Compared with positive control cis-platinum, the high administering drug combinations group pair of cis-platinum~raspberry polysaccharide H460 transplantable tumors growth with conspicuousness inhibitory action (ΔP < 0.05), and the body weight of experimental animal has no significant effect, not See obvious toxicity.
Embodiment 3
Taxol~raspberry polysaccharide is combined the suppression to the growth of the nude mouse xenograft tumor of human liver cancer Bel~7402 and tested
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;High administering drug combinations group in taxol~raspberry polysaccharide, taxol is using subcutaneous Injection, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, and dosage is respectively 200mg/kg, 400mg/kg, often It is administered once.
Inhibitory action of 3. taxols of the table~raspberry polysaccharide to the growth of the nude mouse xenograft tumor of human liver cancer Bel~7402
As a result:It is shown in Table 3, taxol 10mg/kg groups are to the tumour inhibiting rate of the transplanted tumor in nude mice of human liver cancer Bel~7402 68.55%;Taxol~raspberry polysaccharide combines tumour inhibiting rate point of the middle and high dosage group to the transplanted tumor in nude mice of human liver cancer Bel~7402 Not up to 72.47%, 76.47%.Wherein, the inhibition of taxol~raspberry polysaccharide senior middle school administering drug combinations group is higher than taxol list Private medicine group (ΔP < 0.05).And taxol toxicity is larger, the weight of animals declines substantially, and animal has death in experimentation.Two After person is used in combination, experimental animal body weight does not occur animal dead without being decreased obviously in experimentation.
Therefore, taxol~raspberry polysaccharide shows the transplanted tumor in nude mice growth inhibition test result of human liver cancer Bel~7402, Compared with negative control group, taxol 10mg/kg groups, taxol~raspberry polysaccharide senior middle school administering drug combinations group to human liver cancer Bel~ The growth of 7402 transplantable tumors has the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.With positive controls Japanese yew alcohol phase Than taxol~raspberry polysaccharide senior middle school's administering drug combinations have not significant impact to the body weight of experimental animal, have no that obvious poison is secondary anti- Should.
Embodiment 4
Taxol~raspberry polysaccharide is combined to the nude mouse xenograft tumor growth inhibition test of human gastric cancer MGC~803
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;High administering drug combinations group in taxol~raspberry polysaccharide, taxol is using subcutaneous Injection, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, and dosage is respectively 200mg/kg, 400mg/kg, often It is administered once.
Inhibitory action of 4. taxols of the table~raspberry polysaccharide to the growth of the nude mouse xenograft tumor of human gastric cancer MGC~803
As a result:It is shown in Table 4, taxol 10mg/kg groups are to the tumour inhibiting rate of the transplanted tumor in nude mice of human gastric cancer MGC~803 65.26%;Taxol~raspberry polysaccharide combines middle and high dosage group and the tumour inhibiting rate of the transplanted tumor in nude mice of human gastric cancer MGC~803 is distinguished Up to 70.35%, 72.48%.Wherein, the inhibition of taxol~raspberry polysaccharide senior middle school administering drug combinations group is independent higher than taxol Medication group (ΔP < 0.05).And taxol toxicity is larger, the weight of animals declines substantially, and animal has death in experimentation.Both After being used in combination, experimental animal body weight does not occur animal dead without being decreased obviously in experimentation.
Therefore, taxol~raspberry polysaccharide shows the transplanted tumor in nude mice growth inhibition test result of human gastric cancer MGC~803, Compared with negative control group, taxol 10mg/kg groups, taxol~raspberry polysaccharide senior middle school administering drug combinations group to human gastric cancer MGC~ The growth of 803 transplantable tumors has the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.With positive controls Japanese yew alcohol phase Than taxol~raspberry polysaccharide senior middle school's administering drug combinations have not significant impact to the body weight of experimental animal, have no that obvious poison is secondary anti- Should.
Embodiment 5
Taxol~raspberry polysaccharide is combined to the examination of the nude mouse xenograft tumor growth inhibition of human breast carcinoma MDA~MB~231 Test
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;Taxol~raspberry polysaccharide administering drug combinations group, taxol, which uses, to be subcutaneously injected, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, dosage 400mg/kg, are administered once daily.
Suppression of 5. taxols of the table~raspberry polysaccharide to the growth of the nude mouse xenograft tumor of human breast carcinoma MDA~MB~231 Effect
As a result:It is shown in Table 5, taxol 10mg/kg groups are to the tumour inhibiting rate of the transplanted tumor in nude mice of human breast carcinoma MDA~MB~231 70.87%;Inhibitory rate of the taxol~raspberry polysaccharide joint group to the transplanted tumor in nude mice of human breast carcinoma MDA~MB~231 75.36%.Wherein, the inhibition of taxol~raspberry polysaccharide administering drug combinations group higher than taxol independent medication group (ΔP < 0.05).And taxol toxicity is larger, the weight of animals declines substantially, and animal has death in experimentation.After both are used in combination, Experimental animal body weight does not occur animal dead without being decreased obviously in experimentation.
Therefore, taxol~raspberry polysaccharide is to the transplanted tumor in nude mice growth inhibition test result of human breast carcinoma MDA~MB~231 Show, compared with negative control group, taxol 10mg/kg groups, taxol~raspberry polysaccharide administering drug combinations group are to human breast carcinoma MDA The growth of the transplantable tumor of~MB~231 has the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.It is purple with positive controls China fir alcohol is compared, and taxol~raspberry polysaccharide administering drug combinations have not significant impact to the body weight of experimental animal, has no that obvious poison is secondary Reaction.
Embodiment 6
Taxol~raspberry polysaccharide is combined to people's kidney A498 nude mouse xenograft tumor growth inhibition tests
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;High administering drug combinations group in taxol~raspberry polysaccharide, taxol is using subcutaneous Injection, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, and dosage is respectively 200mg/kg, 400mg/kg, often It is administered once.
The inhibitory action that 6. taxols of table~raspberry polysaccharide grows to people kidney A498 nude mouse xenograft tumors
As a result:6 are shown in Table, taxol 10mg/kg groups are 60.21% to the tumour inhibiting rate of people's kidney A498 transplanted tumor in nude mice;It is purple China fir alcohol~raspberry polysaccharide combines middle and high dosage group to the tumour inhibiting rate of people's kidney A498 transplanted tumor in nude mice respectively up to 69.55%, 72.19%.Wherein, in taxol~raspberry polysaccharide high administering drug combinations group inhibition higher than taxol independent medication group (ΔP < 0.05).And taxol toxicity is larger, the weight of animals declines substantially, and animal has death in experimentation.Both are used in combination Afterwards, experimental animal body weight is without being decreased obviously, and does not occur animal dead in experimentation.
Therefore, taxol~raspberry polysaccharide shows people's kidney A498 transplanted tumor in nude mice growth inhibition test results, with the moon Property control group is compared, and taxol 10mg/kg groups, taxol~raspberry polysaccharide senior middle school administering drug combinations group are to people's kidney A498 transplantable tumors Growth have the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.Compared with positive controls taxol, taxol ~raspberry polysaccharide senior middle school's administering drug combinations have not significant impact to the body weight of experimental animal, have no obvious toxicity.
Embodiment 7
Taxol~raspberry polysaccharide is combined the suppression to the growth of the nude mouse xenograft tumor of human colon carcinoma HT~29 and tested
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;Taxol~raspberry polysaccharide administering drug combinations group, taxol, which uses, to be subcutaneously injected, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, dosage 400mg/kg, are administered once daily.
Inhibitory action of 7. taxols of the table~raspberry polysaccharide to the growth of the nude mouse xenograft tumor of human colon carcinoma HT~29
As a result:It is shown in Table 7, taxol 10mg/kg groups are to the tumour inhibiting rate of the transplanted tumor in nude mice of human colon carcinoma HT~29 62.88%;Inhibitory rate 68.23% of the taxol~raspberry polysaccharide joint group to the transplanted tumor in nude mice of human colon carcinoma HT~29.Its In, the inhibition of taxol~raspberry polysaccharide administering drug combinations group higher than taxol independent medication group (ΔP < 0.05).And Japanese yew Alcohol toxicity is larger, and the weight of animals declines substantially, and animal has death in experimentation.After both are used in combination, experimental animal body weight Nothing is decreased obviously, and does not occur animal dead in experimentation.
Therefore, taxol~raspberry polysaccharide shows the transplanted tumor in nude mice growth inhibition test result of human colon carcinoma HT~29, Compared with negative control group, taxol 10mg/kg groups, taxol~raspberry polysaccharide administering drug combinations group are moved to human colon carcinoma HT~29 Planting the growth of knurl has the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.It is purple compared with positive controls taxol China fir alcohol~raspberry polysaccharide administering drug combinations have not significant impact to the body weight of experimental animal, have no obvious toxicity.
Embodiment 8
Taxol~raspberry polysaccharide is combined the suppression to the growth of people carcinoma of endometrium HHUA nude mouse xenograft tumors and tested
Specific embodiment is with reference to embodiment 2.Dosage regimen is as follows:Negative control group injection normal saline, daily 1 It is secondary;Taxol group 10mg/kg, weekly administration 1 time;High administering drug combinations group in taxol~raspberry polysaccharide, taxol is using subcutaneous Injection, 10mg/kg, weekly administration 1 time, raspberry polysaccharide use gavage, and dosage is respectively 200mg/kg, 400mg/kg, often It is administered once.
The inhibitory action that 8. taxols of table~raspberry polysaccharide grows to people carcinoma of endometrium HHUA nude mouse xenograft tumors
As a result:8 are shown in Table, taxol 10mg/kg groups are to the tumour inhibiting rate of people's carcinoma of endometrium HHUA transplanted tumor in nude mice 58.77%;Taxol~raspberry polysaccharide combines tumour inhibiting rate point of the middle and high dosage group to people's carcinoma of endometrium HHUA transplanted tumor in nude mice Not up to 67.21%, 69.34%.Wherein, the inhibition of high administering drug combinations group is higher than taxol list in taxol~raspberry polysaccharide Private medicine group (ΔP < 0.05).And taxol toxicity is larger, the weight of animals declines substantially, and animal has death in experimentation.Two After person is used in combination, experimental animal body weight does not occur animal dead without being decreased obviously in experimentation.
Therefore, taxol~raspberry polysaccharide is to people's carcinoma of endometrium HHUA transplanted tumor in nude mice growth inhibition test result tables Bright, compared with negative control group, taxol 10mg/kg groups, taxol~raspberry polysaccharide senior middle school administering drug combinations group are to people's intrauterine The growth of film cancer HHUA transplantable tumors has the inhibitory action (* P < 0.05, * * P < 0.01) of pole conspicuousness.With positive controls Japanese yew Alcohol is compared, and high administering drug combinations have not significant impact to the body weight of experimental animal in taxol~raspberry polysaccharide, have no obvious poison Side reaction.
Embodiment 9
Raspberry polysaccharide is to tumor-bearing mice liver, the influence of renal tissue form
After each group tumor-bearing mice anesthesia in the anti-tumor experiment of embodiment 1~8, liver and kidney are separated.By liver, kidney Dirty be soaked in 10% formalin is fixed.By the tissue fixed through ethanol dehydration, dimethylbenzene is transparent, FFPE, cuts Piece paster, dimethylbenzene dewaxing, HE dyeing, dehydration is transparent, and sealing is after optical microphotograph Microscopic observation and takes pictures.
The hepatic tissue section of each group mouse is as shown in figure 1, the liver cell edge clear of normal mouse, cytoplasm fill, carefully Karyon is clear, and cell arrangement is neat.By contrast, the liver cell height swelling of chemotherapeutics group mouse, subregion hepatic tissue Focal necrosis, interstitial stove cell infiltration.And the liver cell of chemotherapeutics~raspberry polysaccharide joint group mouse has obvious recovery, The liver cell of wherein chemotherapeutics~raspberry polysaccharide high dose joint group mouse is similar to normal mouse liver cell.It can be seen that raspberry Polysaccharide tumor-bearing mice hepatic injury to caused by chemotherapeutics has certain repair.
The nephridial tissue of each group mouse is cut into slices as shown in Fig. 2 the glomerulus regular shape of normal mouse, Bowman's capsule gap Small, glomerular basement membrane is complete.By contrast, there is certain degeneration and damage in the glomerulus of chemotherapeutics group mouse, specifically Show that glomerular basement membrane distorts, capsula glomeruli gap is substantially widened.The kidney of chemotherapeutics~raspberry polysaccharide joint group mouse is small Ball recovers clearly, to be mainly manifested in capsula glomeruli gap and compared with chemotherapeutics group substantially diminish.It can be seen that raspberry polysaccharide is to chemotherapeutic Tumor-bearing mice injury of kidney also has certain repair caused by thing.
It these results suggest that, raspberry polysaccharide can repair caused lesions of liver and kidney after chemotherapeutic drug therapy, chemotherapeutics and tree Certain kind of berries polysaccharide is used in combination rear toxic side effect and reduced.
Embodiment 10
Influence of the raspberry polysaccharide to tumor-bearing mice index and spleen index
After the anti-tumor experiment of embodiment 1~8 terminates, by mouse anesthesia, tumor tissues and spleen are separated, is weighed.According to title Weight result calculates index and spleen index.Calculation formula:Index and spleen index=spleen weight (g)/net body weight (kg), wherein, net body weight=body Weight~knurl weight.Test obtained result to represent with mean ± SD, and count T inspections, P < 0.05 are significant difference, P < 0.01 is pole significant difference (*:Compared with negative control group, # is compared with chemotherapeutics group).
As a result Fig. 3 is seen.Compared with chemotherapeutics group, the index and spleen index of chemotherapeutics~raspberry polysaccharide administering drug combinations group is aobvious Write increase.
Embodiment 11
The influence of raspberry Polysaccharides on Mice splenic lymphocytes in-vitro multiplication
Cervical dislocation puts to death mouse, is soaked 1~2 minute in 75% ethanol, takes out spleen rapidly in aseptic operating platform, Filled as 400 mesh nylon screens are equipped with advance in ice-cold PBS plate.Spleen tissue is gently twisted with the fingers with sterile nook closing member on screen cloth, is made Individual cells filtration screen cloth enters plate.Cell suspension is collected after rinsing screen cloth with PBS, in 4 DEG C of 5 points of centrifugations (1000r/min) Clock.Supernatant is abandoned, cell is resuspended with the culture medium of the RPMI containing 2%FBS~1640 and counts under the microscope, cell concentration is adjusted For 1 × 107Individual/ml, by cell suspension inoculation into 96 orifice plates, 100 μ l/ holes, and 5 μ g/ml ConA is added into hole, in 37 DEG C, 5%CO2Overnight incubation in incubator.Next day, it is separately added into after raspberry polysaccharide is diluted into each predetermined concentration with nutrient solution In 96 orifice plates (100 μ l/ holes).Using do not add ConA as blank control group, using only plus ConA do not add the group of raspberry polysaccharide as Positive controls.At 37 DEG C, 5%CO2Incubator is incubated 48 hours.5mg/ml MTT is added into 96 orifice plates, per the μ l of hole 20, Continue to cultivate 4h.Culture medium is sopped up, 150 μ l DMSO dissolvings are added per hole, shaking table gently mixes for 10 minutes.Surveyed with ELIASA The a length of 570nm of standing wave, reference wavelength are that light absorption value is determined at 630nm.Test obtained result to represent with mean ± SD, and carry out Count T to examine, P < 0.05 are significant difference, and P < 0.01 are pole significant difference (*:Compared with negative control group, # and sun Property control group is compared).
As a result as shown in figure 4, the light absorption value of raspberry polysaccharide each group is all remarkably higher than negative control group, and dose-dependant is presented Relation.In addition, since 64 μ g/ml, it is significantly higher than positive controls.Thus illustrate, raspberry polysaccharide can significantly stimulate mice spleen The propagation of lymphocyte.
Embodiment 12
Influence of the raspberry polysaccharide to Related Immune Enzyme Activity in tumor-bearing mice splenocyte
By the spleen of each group tumor-bearing mice of embodiment 1~8 under condition of ice bath with cell crushing instrument it is broken (400 amperes, often Secondary 5 seconds, it is repeated 3 times), crushing medium pH7.4,0.01mol/L Tris~HCl, 0.0001mol/L EDTA~2Na, 0.01mol/L sucrose, 0.8%NaCl.Supernatant is collected after centrifuging (5000r/min) 10 minutes in 4 DEG C, is examined respectively with testing cassete Survey the activity of four kinds of immune relevant enzyme AKP, ACP, LDH and SOD in splenocyte.Obtained result is tested with mean ± SD tables Show, and carry out counting T inspections, P < 0.05 are significant difference, and P < 0.01 are pole significant difference (*:With negative control group phase Than # is compared with positive controls).
As a result as shown in figure 5, compared with negative control group, raspberry polysaccharide can be obviously improved the activity of 4 kinds of enzymes, and agent is presented Measure dependence.Compared with chemotherapeutics group, the activity for improving ACP of chemotherapeutics~raspberry polysaccharide joint group conspicuousness. Thus illustrate, after chemotherapeutics is used in combination with raspberry polysaccharide, its raising ability to ACP activity is strengthened.
Embodiment 13
Influence of the raspberry polysaccharide to CD4, CD8, IL in tumor-bearing mice serum~2, INF~γ and TNF~alpha content
Blood is taken by eyeball is extractd after each group tumor-bearing mice anesthesia in the anti-tumor experiment of embodiment 1~8.Blood stands a moment Serum is collected after centrifuging (2500r/min) 10 minutes after 4 DEG C.Detected respectively with enzyme-linked immunologic detecting kit CD4 in serum, CD8, IL~2, INF~γ and TNF~alpha content.Test obtained result to represent with mean ± SD, and carry out counting T inspections, P < 0.05 are significant difference, and P < 0.01 are pole significant difference (*:Compared with negative control group, # and positive controls phase Than).
As a result as shown in fig. 6, compared with positive controls, chemotherapeutics~raspberry polysaccharide joint group can be significantly or extremely aobvious The content of 5 kinds of albumen of raising of work property.Thus illustrate, after docetaxel is used in combination with raspberry polysaccharide, it is to this five kinds of albumen The raising ability of content is strengthened.
Each immunization experiment result further illustrates above, and raspberry polysaccharide can strengthen the immunity of tumor-bearing mice, and greatly The big therapeutic effect for improving chemotherapeutics.

Claims (15)

1. raspberry polysaccharide and purposes of the chemotherapeutics in antitumor combination medicine is prepared.
2. purposes according to claim 1, it is characterised in that:The chemotherapeutics is selected from taxol, cis-platinum or/and more western He matches.
3. purposes according to claim 1, it is characterised in that:The tumour be selected from melanoma, lung cancer, liver cancer, stomach cancer, Breast cancer, kidney, carcinoma of endometrium or colon cancer.
4. purposes according to claim 1, it is characterised in that:The chemotherapeutics uses injection type.
5. purposes according to claim 1, it is characterised in that:The raspberry polysaccharide uses peroral dosage form.
6. according to the purposes described in Claims 1 to 5 any one, it is characterised in that:The use of raspberry polysaccharide and chemotherapeutics Dose ratio is 20~40: 1w/w.
7. according to the purposes described in Claims 1 to 5 any one, it is characterised in that:In the raspberry polysaccharide, purity of polysaccharide exists More than 50%.
8. purposes according to claim 7, it is characterised in that:Purity of polysaccharide is more than 80%.
9. purposes according to claim 8, it is characterised in that:Purity of polysaccharide is more than 85%.
10. purposes according to claim 9, it is characterised in that:Purity of polysaccharide is 85~95%w/w.
11. according to the purposes described in Claims 1 to 5 any one, it is characterised in that:The raspberry polysaccharide uses water extract-alcohol precipitation Method is prepared.
12. purposes according to claim 11, it is characterised in that:The water extraction and alcohol precipitation method concrete operations are as follows:Take drying After raspberry, petroleum ether or ether defatting, extracted with 75~95%v/v of concentration ethanol, filtering, filter residue extracting in water, extract of fetching water After concentration, add ethanol to alcohol content to reach 75%~85%, cooling, stand, it is raspberry polysaccharide to take solid content.
13. purposes according to claim 12, it is characterised in that:Remove seed or non-remove seed before raspberry extraction.
14. according to the purposes described in Claims 1 to 5 any one, it is characterised in that:The raspberry is rose family rubus The fruit of plant.
15. purposes according to claim 14, it is characterised in that:The raspberry is selected from raspberry or black raspberry.
CN201510169863.6A 2015-04-04 2015-04-04 Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics Active CN104857018B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510169863.6A CN104857018B (en) 2015-04-04 2015-04-04 Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510169863.6A CN104857018B (en) 2015-04-04 2015-04-04 Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics

Publications (2)

Publication Number Publication Date
CN104857018A CN104857018A (en) 2015-08-26
CN104857018B true CN104857018B (en) 2018-03-06

Family

ID=53903485

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510169863.6A Active CN104857018B (en) 2015-04-04 2015-04-04 Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics

Country Status (1)

Country Link
CN (1) CN104857018B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105254773A (en) * 2015-10-27 2016-01-20 齐齐哈尔医学院 Preparation method of antitumor polysaccharide
CN112538121B (en) * 2020-12-09 2021-10-22 青海大学 Polysaccharide SM-0.4M and anti-tumor product prepared from same
CN112358553B (en) * 2020-12-09 2021-10-01 青海大学 Polysaccharide SM-0.2M and anti-tumor product prepared from same
CN115414465A (en) * 2022-10-17 2022-12-02 苏州明人医药生物科技有限公司 Application of JWA polypeptide in preparation of antitumor drug synergist

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731668A (en) * 2011-04-12 2012-10-17 谭智丽 Method for extracting and purifying Codonopsis pilosula polysaccharide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731668A (en) * 2011-04-12 2012-10-17 谭智丽 Method for extracting and purifying Codonopsis pilosula polysaccharide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
覆盆子多糖提取、结构分析及自由基清除作用研究;刘明学等;《食品科技》;20091231;第34卷(第7期);第163-167页 *

Also Published As

Publication number Publication date
CN104857018A (en) 2015-08-26

Similar Documents

Publication Publication Date Title
CN101485655B (en) Application of dihydromyricetin in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
CN104873532B (en) Application of the raspberry polysaccharide in antitumor
CN104857018B (en) Raspberry polysaccharide prepares the purposes of antineoplastic combination medication with chemotherapeutics
US10967017B2 (en) Traditional Chinese medicine composition and use thereof
CN105017438B (en) A kind of Radix et Rhizoma Gynurae divaricatae polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food
CN104800174B (en) A kind of raspberry polysaccharide buccal tablet and application thereof
CN102905715B (en) Coumestrol or the bean extract containing coumestrol are for the preparation of the purposes in the compositions of enhancing immunity
CN104193845B (en) A kind of Nostoc commune antitumor polysaccharide and its preparation method and application
CN105664140A (en) Glycopeptide composition as well as preparation method and application thereof
CN104367853A (en) Aquatic plant compound, extraction method of polysaccharide in aquatic plant compound, and novel use of polysaccharide in aquatic plant compound
CN101791363B (en) Broad spectrum anticancer vegetable drug, preparation method and application thereof
US11026988B2 (en) Traditional Chinese medicine composition and use thereof
US10967016B2 (en) Traditional Chinese medicine composition and use thereof
CN104758270B (en) A kind of raspberry polysaccharide effervescence tablet and application thereof
CN104825387B (en) A kind of raspberry polyoses oral liquid and application thereof
CN104857011B (en) Raspberry polysaccharide prevents or the application for the treatment of toxic and side
CN107519327A (en) A kind of Phellinus Chinese medicine composition and its extracting method and the application in antineoplastic is prepared
CN105412155B (en) Trichoderma pseudokoningii exocellular polysaccharide treats and prevents the application of colon cancer and its is combined the application of chemotherapeutic drug therapy colon cancer
CN101983633B (en) New application of polysaccharides from fructus rosae roxburghii for protection against ionizing radiation
CN100589812C (en) Plant worms mycelium extracat fraction and composition for oral intake
KR100316379B1 (en) Chinese medicine for cancer treatment
CN102805829B (en) Preparation method of rhizoma smilacis glabrae extract and applications thereof in tumor treatment
CN101711790A (en) Wild Juglans mandshurica bark water extract used for curing liver cancer
CN105012366B (en) A kind of bright moon grass polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food
CN103599167B (en) A kind of medicament for the treatment of pulmonary carcinoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant